Showing results (2201-2210 of 2,591) with videos related to
Sort By:
Pageof 260
Brain Communications|September 21, 2020
Single-subject grey matter network trajectories over the disease course of autosomal dominant Alzheimer's diseaseLisa Vermunt, Ellen Dicks, Guoqiao Wang, et al.Annals of Neurology|September 22, 2025
Cross-Sectional FDG in Down Syndrome and Autosomal Dominant Alzheimer's DiseaseOmar Abdelmoity, Julie K Wisch, James T Kennedy, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 13, 2018
Utility of perfusion PET measures to assess neuronal injury in Alzheimer's diseaseNelly Joseph-Mathurin, Yi Su, Tyler M Blazey, et al.Open Forum Infectious Diseases|March 27, 2024
The Enterics for Global Health (EFGH) Shigella Surveillance Study in MalawiDonnie Mategula, Maureen Ndalama, Clement Lefu, et al.Brain : a Journal of Neurology|February 13, 2019
Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkersBrian A Gordon, Tyler M Blazey, Jon Christensen, et al.Cell|August 12, 2014
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of originKatherine A Hoadley, Christina Yau, Denise M Wolf, et al.Brain Connectivity|January 12, 2021
Resting-State Functional Connectivity Disruption as a Pathological Biomarker in Autosomal Dominant Alzheimer DiseaseRobert X Smith, Jeremy F Strain, Aaron Tanenbaum, et al.Human Brain Mapping|October 23, 2023
T1 and FLAIR signal intensities are related to tau pathology in dominantly inherited Alzheimer diseaseFarzaneh Rahmani, Matthew R Brier, Brian A Gordon, et al.Molecular Psychiatry|February 26, 2020
Brain and blood biomarkers of tauopathy and neuronal injury in humans and rats with neurobehavioral syndromes following blast exposureDara L Dickstein, Rita De Gasperi, Miguel A Gama Sosa, et al.Science (New York, N.Y.)|October 23, 1998
An MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbitsJ R Wetterau, R E Gregg, T W Harrity, et al.Pageof 260